RG
MYOK

Redmile Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Redmile Group’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,182
Closed -$375K – 84
2019
Q3 		$375K Buy
7,182
+930
+15% +$49.5K 0.01% 62
2019
Q2 		$313K Hold
6,252
– – 0.01% 71
2019
Q1 		$325K Sell
6,252
-1,678
-21% -$77.3K 0.01% 71
2018
Q4 		$387K Buy
7,930
+760
+11% +$41.8K 0.02% 67
2018
Q3 		$467K Hold
7,170
– – 0.01% 72
2018
Q2 		$356K Buy
+7,170
New +$347K 0.01% 71

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Redmile Group's MYOK Position: Q4 2019 in Review

Redmile Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2019, closing a stake of 7,182 shares — an estimated $375K sold.

Redmile Group first reported a position in MYOK in Q2 2018 and held it in 6 quarters. The position peaked at $467K in Q3 2018. 178 funds tracked by Wall St. Rank hold MYOK as of Q4 2019.

  • Redmile Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Redmile Group sold 7,182 MyoKardia, Inc. Common Stock shares in Q4 2019, an estimated $375K.
  • Redmile Group first reported a position in MyoKardia, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
  • Redmile Group's MyoKardia, Inc. Common Stock position peaked at $467K in Q3 2018.
  • 178 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2019.

Based on Redmile Group's 13F filing for Q4 2019, filed 14 Feb 2020.